IL6R and cancer: In order to examine whether STAT3 signaling is also activated in the residual cancer cells after chemoradiotherapy, the expression of IL-6R and p-STAT3 was further examined immunohistochemically in the 12 patients of the high expression group with poor response to chemoradiotherapy.